Terms: = Uterine cancer AND CREBBP, CBP, 1387, ENSG00000005339, RSTS, RTS AND Treatment
13 results:
1. Carboplatin-loaded ultradeformable vesicles for the management of endometrial cancer:
Patel C; Shukla T; Thakkar H
Ther Deliv; 2023 Feb; 14(2):105-119. PubMed ID: 37125431
[No Abstract] [Full Text] [Related]
2. FTO-stabilized lncRNA HOXC13-AS epigenetically upregulated FZD6 and activated Wnt/β-catenin signaling to drive cervical cancer proliferation, invasion, and EMT.
Wang T; Li W; Ye B; Zhang S; Lei X; Zhang D
J BUON; 2021; 26(4):1279-1291. PubMed ID: 34564982
[TBL] [Abstract] [Full Text] [Related]
3. Non-open-heart surgery for intravascular leiomyomatosis extending from the inferior vena cava to the right heart chamber.
Xu X; Ma G; Miao Q; Liu X; Zhang C; Liu J; Shao J; Cheng N; Cao D
J Vasc Surg Venous Lymphat Disord; 2022 Mar; 10(2):409-416. PubMed ID: 34252578
[TBL] [Abstract] [Full Text] [Related]
4. Combination treatment of Cervical cancer Using Folate-Decorated, pH-Sensitive, Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles.
Wang J
Drug Des Devel Ther; 2020; 14():823-832. PubMed ID: 32161442
[TBL] [Abstract] [Full Text] [Related]
5. Investigation on the Genomic Characterization of uterine Sarcoma for rAd-
Xia Y; Wang L; Ma X; Li X
Hum Gene Ther; 2020 Aug; 31(15-16):881-890. PubMed ID: 32013587
[TBL] [Abstract] [Full Text] [Related]
6. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
7. Intention-to-Treat Analysis of Radical Trachelectomy for Early-Stage Cervical cancer With Special Reference to Oncologic Failures: Single-Institutional Experience in Hungary.
Póka R; Molnár S; Daragó P; Lukács J; Lampé R; Krasznai Z; Hernádi Z
Int J Gynecol Cancer; 2017 Sep; 27(7):1438-1445. PubMed ID: 28604460
[TBL] [Abstract] [Full Text] [Related]
8. Reproducibility and interoperator reliability of obtaining images and measurements of the cervix and uterus with brachytherapy treatment applicators in situ using transabdominal ultrasound.
van Dyk S; Garth M; Oates A; Kondalsamy-Chennakesavan S; Schneider M; Bernshaw D; Narayan K
Brachytherapy; 2016; 15(1):71-8. PubMed ID: 26614235
[TBL] [Abstract] [Full Text] [Related]
9. Can we shorten the overall treatment time in postoperative brachytherapy of endometrial carcinoma? Comparison of two brachytherapy schedules.
Rovirosa A; Ascaso C; Arenas M; Sabater S; Herreros A; Camarasa A; Rios I; Holub K; Pahisa J; Biete A
Radiother Oncol; 2015 Jul; 116(1):143-8. PubMed ID: 26194144
[TBL] [Abstract] [Full Text] [Related]
10. Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma.
Kashima H; Horiuchi A; Uchikawa J; Miyamoto T; Suzuki A; Ashida T; Konishi I; Shiozawa T
Anticancer Res; 2009 Apr; 29(4):1023-9. PubMed ID: 19414341
[TBL] [Abstract] [Full Text] [Related]
11. A prospective study to assess the bladder distension effects on dosimetry in intracavitary brachytherapy of cervical cancer via computed tomography-assisted techniques.
Sun LM; Huang HY; Huang EY; Wang CJ; Ko SF; Lin H; Song JC
Radiother Oncol; 2005 Oct; 77(1):77-82. PubMed ID: 15885826
[TBL] [Abstract] [Full Text] [Related]
12. Inhibition of human papillomavirus-16 long control region activity by interferon-gamma overcome by p300 overexpression.
Fontaine V; van der Meijden E; ter Schegget J
Mol Carcinog; 2001 May; 31(1):27-36. PubMed ID: 11398195
[TBL] [Abstract] [Full Text] [Related]
13. Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma.
Resbeut M; Cowen D; Viens P; Noirclerc M; Perez T; Gouvernet J; Delpero JR; Gamerre M; Boubli L; Houvenaeghel G
Gynecol Oncol; 1994 Jul; 54(1):68-75. PubMed ID: 8020842
[TBL] [Abstract] [Full Text] [Related]
